Reposted by Sharon Roman (n of 1)
As more #MS treatments undergo clinical trials needed for regulatory approval for use in paediatric onset MS, treatment for those < 18 is changing.
But a new study has found starting treatment under age 18 still low. 😔
It’s explained: tremlettsmsresearchexplained.wordpress.com/2026/09/23/d...
tremlettsmsresearchexplained.wordpress.com
Disease-modifying therapy uptake in a pediatric-onset multiple sclerosis population, British Columbia, Canada explained
by Sharon Roman[i] Treatment for those with paediatric-onset multiple sclerosis (POMS), defined as MS onset under age 18, is changing.as more disease modifying therapies go through the clinical tri…